Interparfums (NASDAQ:IPAR – Get Free Report) and Niagen Bioscience (NASDAQ:NAGE – Get Free Report) are both consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.
Valuation & Earnings
This table compares Interparfums and Niagen Bioscience”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Interparfums | $1.49 billion | 2.53 | $168.39 million | $5.23 | 22.50 |
| Niagen Bioscience | $129.42 million | 1.87 | $17.38 million | $0.18 | 16.92 |
Institutional & Insider Ownership
55.6% of Interparfums shares are held by institutional investors. Comparatively, 15.4% of Niagen Bioscience shares are held by institutional investors. 43.6% of Interparfums shares are held by insiders. Comparatively, 10.0% of Niagen Bioscience shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares Interparfums and Niagen Bioscience’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Interparfums | 11.17% | 15.21% | 10.85% |
| Niagen Bioscience | 12.39% | 17.95% | 13.17% |
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Interparfums and Niagen Bioscience, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Interparfums | 2 | 4 | 2 | 1 | 2.22 |
| Niagen Bioscience | 0 | 1 | 3 | 1 | 3.00 |
Interparfums presently has a consensus target price of $123.29, suggesting a potential upside of 4.76%. Niagen Bioscience has a consensus target price of $10.33, suggesting a potential upside of 239.35%. Given Niagen Bioscience’s stronger consensus rating and higher probable upside, analysts clearly believe Niagen Bioscience is more favorable than Interparfums.
Volatility & Risk
Interparfums has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Comparatively, Niagen Bioscience has a beta of 2.09, suggesting that its share price is 109% more volatile than the S&P 500.
About Interparfums
Inter Parfums, Inc., together with its subsidiaries, manufactures, markets, and distributes a range of fragrances and fragrance related products in the United States and internationally. It operates in two segments, European Based Operations and United States Based Operations. The company offers its fragrance and cosmetic products under the Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, Rochas, S.T. Dupont, Van Cleef & Arpels, Abercrombie & Fitch, Anna Sui, Donna Karan, DKNY, Emanual Ungaro, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta, Ungaro, and Roberto Cavalli brands, as well as French Connection, Intimate, and Dunhill, Lacoste names. It sells its products to department stores, perfumeries, specialty stores, duty free shops, and domestic and international wholesalers, and distributors, as well as through e-commerce. The company was formerly known as Jean Philippe Fragrances, Inc. and changed its name to Inter Parfums, Inc. in July 1999. Inter Parfums, Inc. was founded in 1982 and is headquartered in New York, New York.
About Niagen Bioscience
Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.
Receive News & Ratings for Interparfums Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Interparfums and related companies with MarketBeat.com's FREE daily email newsletter.
